A three-year old immunocompromised child receiving oseltamivir for a 2009 pandemic influenza A virus infection developed drug resistance. A nebulized treatment based on Zanamivir aqueous solution was started and carried out for ten days resulting in clinical improvement and viral clearance without significant side effects. See attached fil
Emergence of multidrug resistant influenza A(H1N1)pdm09 virus variants in an immunocompromised child...
Neuraminidase inhibitors are the mainstay of anti-influenza treatment. Oseltamivir is the most widel...
Influenza A (H5N1) virus with an amino acid substitution in neuraminidase conferring high-level resi...
A three-year old immunocompromised child receiving oseltamivir for a 2009 pandemic influenza A virus...
Background: Oseltamivir is considered the drug of choice for patients with pandemic influenza for wh...
Prolonged treatment of an immunocompromised child with oseltamivir and zanamivir for A(H1N1)pdm09 vi...
Background.Oseltamivir, a specific influenza neuraminidase inhibitor, is an effective treatment for ...
During May 2009–April 2010, we analyzed 692 samples of pandemic (H1N1) 2009 virus from patients in M...
Every year 3 to 5 million people suffer from flu. Children are most susceptible to flu. At the momen...
Oseltamivir, a selective neuraminidase enzyme inhibitor, has gained worldwide attention in view of I...
Peramivir is a new neuraminidase inhibitor for intravenous administration that was first introduced ...
The influenza A (H1N1) virus responsible for the 2009 pandemic follows a more severe course in child...
Antiviral agents are available that are safe and effective for the treatment and prophylaxis of infl...
Flu in children is characterized by high incidence, often development of complications, long virus e...
Infants and children are the most effective transmitters of influenza, while bearing a high risk of ...
Emergence of multidrug resistant influenza A(H1N1)pdm09 virus variants in an immunocompromised child...
Neuraminidase inhibitors are the mainstay of anti-influenza treatment. Oseltamivir is the most widel...
Influenza A (H5N1) virus with an amino acid substitution in neuraminidase conferring high-level resi...
A three-year old immunocompromised child receiving oseltamivir for a 2009 pandemic influenza A virus...
Background: Oseltamivir is considered the drug of choice for patients with pandemic influenza for wh...
Prolonged treatment of an immunocompromised child with oseltamivir and zanamivir for A(H1N1)pdm09 vi...
Background.Oseltamivir, a specific influenza neuraminidase inhibitor, is an effective treatment for ...
During May 2009–April 2010, we analyzed 692 samples of pandemic (H1N1) 2009 virus from patients in M...
Every year 3 to 5 million people suffer from flu. Children are most susceptible to flu. At the momen...
Oseltamivir, a selective neuraminidase enzyme inhibitor, has gained worldwide attention in view of I...
Peramivir is a new neuraminidase inhibitor for intravenous administration that was first introduced ...
The influenza A (H1N1) virus responsible for the 2009 pandemic follows a more severe course in child...
Antiviral agents are available that are safe and effective for the treatment and prophylaxis of infl...
Flu in children is characterized by high incidence, often development of complications, long virus e...
Infants and children are the most effective transmitters of influenza, while bearing a high risk of ...
Emergence of multidrug resistant influenza A(H1N1)pdm09 virus variants in an immunocompromised child...
Neuraminidase inhibitors are the mainstay of anti-influenza treatment. Oseltamivir is the most widel...
Influenza A (H5N1) virus with an amino acid substitution in neuraminidase conferring high-level resi...